Clinical features and treatment outcomes of upper gastrointestinal bleeding in patients with cirrhosis

Journal of Korean Medical Science

Volumn 23, Issue 4, 2008, Pages 635-643

  Yeon, Seok Seo ^a   Youn, Ho Kim ^a   Sang, Hoon Ahn ^b   Sang, Kyun Yu ^c   Soon, Koo Baik ^d   Sung, Kyu Choi ^e   Heo, Jeong ^f   Hahn, Taeho ^g   Tae, Woo Yoo ^h   Se, Hyun Cho ⁱ   Hyun, Woong Lee ^b   Ju, Hyun Kim ^c   Cho, Mong ^f   Sang, Hoon Park ^g   Byung, Ik Kim ^h   Kwang, Hyub Han ^b   Soon, Ho Um ^a  

^a Korea University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Gachon University College of Medicine   (South Korea)

^d Yonsei University Wonju   (South Korea)

^e Chonnam National University Medical School   (South Korea)

^f Pusan National University School of Medicine   (South Korea)

^g Hallym University   (South Korea)

^h Sungkyunkwan University School of Medicine   (South Korea)

ⁱ The Catholic University of Korea   (South Korea)

Author keywords

Hemorrhage; Hemostasis; Liver cirrhosis; Prevention and control; Prognosis; Varicose veins

Indexed keywords

DRUG DERIVATIVE; LYPRESSIN; TERLIPRESSIN;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMOSTASIS; HUMAN; INFECTION; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MORTALITY; TREATMENT OUTCOME;

ADULT; AGED; COHORT STUDIES; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMOSTATIC TECHNIQUES; HUMANS; INFECTION; LIVER CIRRHOSIS; LYSINE VASOPRESSIN; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 50449091054     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2008.23.4.635     Document Type: Article

References (29)

1. Nachlas MM, O'Neil JE, Campbell AJ. The life history of patients with cirrhosis of the liver and bleeding esophageal varices. Ann Surg 1955; 141: 10-23.
2. Graham DY, Smith JL. The course of patients after variceal hemorrhage. Gastroenterology 1981; 80: 800-9.
3. Pinto HC, Abrantes A, Esteves AV, Almeida H, Correia JP. Long-term prognosis of patients with cirrhosis of the liver and upper gastrointestinal bleeding. Am J Gastroenterol 1989; 84: 1239-43.
4. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646-9.
5. Carbonell N, Pauwels A, Serfaty L, Fourdan O, Levy VG, Poupon R. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology 2004; 40: 652-9.
6. El-Serag HB, Everhart JE. Improved survival after variceal hemorrhage over an 11-year period in the Department of Veterans Affairs. Am J Gastroenterol 2000; 95: 3566-73.
7. McCormick PA, O'Keefe C. Improving prognosis following a first variceal haemorrhage over four decades. Gut 2001; 49: 682-5.
8. Chalasani N, Kahi C, Francois F, Pinto A, Marathe A, Bini EJ, Pandya P, Sitaraman S, Shen J. Improved patient survival after acute variceal bleeding: a multicenter, cohort study. Am J Gastroenterol 2003; 98: 653-9.
9. D'Amico G, De Franchis R. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology 2003; 38: 599-612.
10. Lebrec D, Poynard T, Hillon P, Benhamou JP. Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a controlled study. N Engl J Med 1981; 305: 1371-4.
11. D'Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analytic review. Hepatology 1995; 22: 332-54.
12. Laine L, Cook D. Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding. A meta-analysis. Ann Intern Med 1995; 123: 280-7.
13. Goulis J, Armonis A, Patch D, Sabin C, Greenslade L, Burroughs AK. Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage. Hepatology 1998; 27: 1207-12.
14. de Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2005; 43: 167-76.
15. Park DK, Um SH, Lee JW, Lee JB, Kim YS, Park CH, Jin YT, Chun HJ, Lee HS, Lee SW, Choi JH, Kim CD, Ryu HS, Hyun JH. Clinical significance of variceal hemorrhage in recent years in patients with liver cirrhosis and esophageal varices. J Gastroenterol Hepatol 2004; 19: 1042-51.
16. Beppu K, Inokuchi K, Koyanagi N, Nakayama S, Sakata H, Kitano S, Kobayashi M. Prediction of variceal hemorrhage by esophageal endoscopy. Gastrointest Endosc 1981; 27: 213-8.
17. Sarin SK, Lahoti D, Saxena SP, Murthy NS, Makwana UK. Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients. Hepatology 1992; 16: 1343-9.
18. de Franchis R. Developing consensus in portal hypertension. J Hepatol 1996; 25: 390-4.
19. de Franchis R. Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol 2000; 33: 846-52.
20. Pauwels A, Mostefa-Kara N, Debenes B, Degoutte E, Levy VG. Systemic antibiotic prophylaxis after gastrointestinal hemorrhage in cirrhotic patients with a high risk of infection. Hepatology 1996; 24: 802-6.
21. Kim YS, Um SH, Ryu HS, Lee JB, Lee JW, Park DK, Kim YS, Jin YT, Chun HJ, Lee HS, Lee SW, Choi JH, Kim CD, Hyun JH. The prognosis of liver cirrhosis in recent years in Korea. J Korean Med Sci 2003; 18: 833-41.
22. Luca A, Garcia-Pagan JC, Bosch J, Feu F, Caballeria J, Groszmann RJ, Rodes J. Effects of ethanol consumption on hepatic hemodynamics in patients with alcoholic cirrhosis. Gastroenterology 1997; 112: 1284-9.
23. Oshita M, Takei Y, Kawano S, Yoshihara H, Hijioka T, Fukui H, Goto M, Masuda E, Nishimura Y, Fusamoto H, Kamada T. Roles of endothelin-1 and nitric oxide in the mechanism for ethanol-induced vasoconstriction in rat liver. J Clin Invest 1993; 91: 1337-42.
24. Heresbach D, Jacquelinet C, Nouel O, Chaperon J, Bretagne JF, Gosselin M. Sclerotherapy versus ligation in hemorrhage caused by rupture of esophageal varices. Direct meta-analysis of randomized trials. Gastroenterol Clin Biol 1995; 19: 914-20.
25. Burroughs AK, Jenkins WJ, Sherlock S, Dunk A, Walt RP, Osuafor TO, Mackie S, Dick R. Controlled trial of propranolol for the prevention of recurrent variceal hemorrhage in patients with cirrhosis. N Engl J Med 1983; 309: 1539-42.
26. Garden OJ, Mills PR, Birnie GG, Murray GD, Carter DC. Propranolol in the prevention of recurrent variceal hemorrhage in cirrhotic patients. A controlled trial. Gastroenterology 1990; 98: 185-90.
27. Bernard B, Lebrec D, Mathurin P, Opolon P, Poynard T. Beta-adrenergic antagonists in the prevention of gastrointestinal rebleeding in patients with cirrhosis: a meta-analysis. Hepatology 1997; 25: 63-70.
28. Sarin SK, Wadhawan M, Gupta R, Shahi H. Evaluation of endoscopic variceal ligation (EVL) versus propanolol plus isosorbide mononitrate/nadolol (ISMN) in the prevention of variceal rebleeding: comparison of cirrhotic and noncirrhotic patients. Dig Dis Sci 2005; 50: 1538-47.
29. Poynard T, Cales P, Pasta L, Ideo G, Pascal JP, Pagliaro L, Lebrec D. Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multicenter Study Group. N Engl J Med 1991; 324: 1532-8.